Skip to content
Doctors’ Choice Awards. Doctors Know Doctors Best!
My Account

Family & General Practitioners

Sumanta Kuma Pal, MD

City of Hope - Main Campus (Duarte) · Duarte, CA

Identity verified on September 21, 2026

Listed since 2015

1 Peer Endorsement

5.0

Endorse This Doctor

Has endorsed Dr. Dorrie E. Chang and Dr. Dana L. Tarcatu.

  • “I had the pleasure to work collaboratively, as a Palliative Care consultant, with Dr. Pal at City of Hope. Despite his young age, he is already an accomplished academician with an impressive portfolio. He is very much loved and appreciated by his patients and colleagues. His passion to learn and share knowledge make him a great teacher and mentor to his fellows, who are very lucky to have him as a role model.”Read more

    “I had the pleasure to work collaboratively, as a Palliative Care consultant, with Dr. Pal at City of Hope. Despite his young age, he is already an accomplished academician with an impressive portfolio. He is very much loved and appreciated by his patients and colleagues. His passion to learn and share knowledge make him a great teacher and mentor to his fellows, who are very lucky to have him as a role model.”

    Dana Tarcatu, MDInternal Medicine, Hospice and Palliative Medicine · New York, NYApril 27, 2015

Any verified healthcare professional can endorse, once per colleague per cycle.

About

Sumanta Kumar Pal, M.D., is an assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney Cancer Program at City of Hope. Read more

Sumanta Kumar Pal, M.D., is an assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney Cancer Program at City of Hope. Having been appointed to the faculty for just over four years, Dr. Pal has been extremely productive, publishing more than 80 manuscripts in peer-reviewed journals. He has presented his work in multiple international meetings.

2006-present, American Society of Clinical Oncology (ASCO) (2006- present)

National Comprehensive Cancer Network Bladder Cancer Committee (2010-present)

HER2-Positive Breast Cancer Committee, ASCO (2012-2013)

Genitourinary Cancers Committee, ASCO (2013-present )

Recognition history

No recognition on record yet.

Something wrong?

Correct anything that is wrong here, or ask to be removed. We acknowledge within 5 business days and resolve within 10.